Richard Bevan-Thomas

420 total citations
9 papers, 271 citations indexed

About

Richard Bevan-Thomas is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Richard Bevan-Thomas has authored 9 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Rheumatology. Recurrent topics in Richard Bevan-Thomas's work include Genital Health and Disease (3 papers), Urologic and reproductive health conditions (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Richard Bevan-Thomas is often cited by papers focused on Genital Health and Disease (3 papers), Urologic and reproductive health conditions (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Richard Bevan-Thomas collaborates with scholars based in United States and Canada. Richard Bevan-Thomas's co-authors include Curtis A. Pettaway, Joel W. Slaton, O. Lenaine Westney, Edward J. McGuire, R. Duane Cespedes, J. Lynn Palmer, David R. Wise, Robert F. Cornell, David Cahn and Ivan Grunberger and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

Richard Bevan-Thomas

7 papers receiving 265 citations

Peers

Richard Bevan-Thomas

RHEUM

SURGE

UROLO

PRM

EPIDE

Sue Heenan United Kingdom

Alessandro Tavares Brazil

C Calabuig Spain

Murali R. Kamat India

Michelle Koski United States

L.I. Okeke Nigeria

Carmelo Caballero Paraguay

Garson Chan Canada

Xavier Biardeau France

Feras Alhalabi United States

Sue Heenan United Kingdom

Richard Bevan-Thomas

189 ×0.9

RHEUM

228 ×1.0

SURGE

160 ×0.9

UROLO

14 ×0.3

PRM

28 ×1.3

EPIDE

Citations per year, relative to Richard Bevan-Thomas Richard Bevan-Thomas (= 1×) peers Sue Heenan

Countries citing papers authored by Richard Bevan-Thomas

Since Specialization

Citations

This map shows the geographic impact of Richard Bevan-Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bevan-Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bevan-Thomas more than expected).

Fields of papers citing papers by Richard Bevan-Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Bevan-Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bevan-Thomas. The network helps show where Richard Bevan-Thomas may publish in the future.

Co-authorship network of co-authors of Richard Bevan-Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Bevan-Thomas. A scholar is included among the top collaborators of Richard Bevan-Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Bevan-Thomas. Richard Bevan-Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Shore, Neal D., David Cahn, Christopher Pieczonka, et al.. (2021). PD13-10 UNIVERSAL GERMLINE TESTING OF PROSTATE CANCER PATIENTS: ARE GENETIC TESTING GUIDELINES AN IMPEDIMENT TO PRECISION THERAPY?. The Journal of Urology. 206(Supplement 3). 1 indexed citations

2.

Hardwick, Mary Kay, Edward D. Esplin, David Morris, et al.. (2021). 628P Universal germline testing of prostate cancer patients: Are genetic testing guidelines an aid or an impediment to precision therapy?. Annals of Oncology. 32. S663–S663. 1 indexed citations

3.

Esplin, Edward D., Christopher Pieczonka, Laurence Belkoff, et al.. (2021). Underdiagnosis of germline genetic prostate cancer: Are genetic testing guidelines an aid or an impediment?. Journal of Clinical Oncology. 39(15_suppl). 10504–10504. 5 indexed citations

4.

Robertson, Cary N., Anthony J. Sliwinski, Eric Wallen, et al.. (2016). MP18-15 EFFICACY OF HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) AS A PRIMARY MONOTHERAPY FOR LOW RISK LOCALIZED PROSTATE CANCER: OUTCOMES FROM THE ENLIGHT TRIAL. The Journal of Urology. 195(4S).

5.

Sliwinski, Anthony J., Eric Wallen, John F. Ward, et al.. (2011). POD-07.08 Morbidity of High Intensity Focused Ultrasound (HIFU) as a Primary Monotherapy for Low-Risk Localized Prostate Cancer: Outcomes from the ENLIGHT Trial. Urology. 78(3). S25–S26. 1 indexed citations

6.

Westney, O. Lenaine, Richard Bevan-Thomas, J. Lynn Palmer, R. Duane Cespedes, & Edward J. McGuire. (2005). TRANSURETHRAL COLLAGEN INJECTIONS FOR MALE INTRINSIC SPHINCTER DEFICIENCY: THE UNIVERSITY OF TEXAS-HOUSTON EXPERIENCE. The Journal of Urology. 174(3). 994–997. 44 indexed citations

7.

Bevan-Thomas, Richard, Joel W. Slaton, & Curtis A. Pettaway. (2002). Contemporary Morbidity From Lymphadenectomy For Penile Squamous Cell Carcinoma: The M.D. Anderson Cancer Center Experience. The Journal of Urology. 1638–1642. 14 indexed citations

8.

Bevan-Thomas, Richard, Joel W. Slaton, & Curtis A. Pettaway. (2002). Contemporary Morbidity From Lymphadenectomy For Penile Squamous Cell Carcinoma: The M.D. Anderson Cancer Center Experience. The Journal of Urology. 167(4). 1638–1642. 199 indexed citations

9.

Bevan-Thomas, Richard, O. Lenaine Westney, Edward J. McGuire, & R. Duane Cespedes. (1999). LONG-TERM FOLLOW-UP OF PERIURETHRAL COLLAGEN INJECTIONS FOR MALE INTRINSIC SPHINCTER DEFICIENCY. The Journal of Urology. 257–257. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact